Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells
- PMID: 18593018
- DOI: 10.1007/978-0-387-73898-7_8
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells
Similar articles
-
Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.Clin Cancer Res. 2004 May 15;10(10):3535-41. doi: 10.1158/1078-0432.CCR-03-0512. Clin Cancer Res. 2004. PMID: 15161713
-
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.Hum Gene Ther. 2006 Dec;17(12):1225-40. doi: 10.1089/hum.2006.17.1225. Hum Gene Ther. 2006. PMID: 17107337
-
A probable role for trail-induced apoptosis in the pathogenesis of marrow failure. Implications from an in vitro model and from marrow of aplastic anemia patients.Leuk Res. 2006 Jun;30(6):713-21. doi: 10.1016/j.leukres.2005.09.015. Epub 2005 Nov 28. Leuk Res. 2006. PMID: 16310248
-
TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.Int J Biochem Cell Biol. 2009 Mar;41(3):460-6. doi: 10.1016/j.biocel.2007.12.012. Epub 2007 Dec 28. Int J Biochem Cell Biol. 2009. PMID: 18243765 Review.
-
TRAIL as a target in anti-cancer therapy.Cancer Lett. 2009 Nov 18;285(1):1-5. doi: 10.1016/j.canlet.2009.02.029. Epub 2009 Mar 18. Cancer Lett. 2009. PMID: 19299078 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical